Cogent Biosciences, Inc. (COGT)
NASDAQ: COGT · Real-Time Price · USD
16.35
+0.35 (2.19%)
Oct 30, 2025, 12:59 PM EDT - Market open
Cogent Biosciences Market Cap
Cogent Biosciences has a market cap or net worth of $2.29 billion as of October 30, 2025. Its market cap has increased by 84.62% in one year.
Market Cap
2.29B
Enterprise Value
2.06B
1-Year Change
84.62%
Ranking
Category
Stock Price
$16.35
Market Cap Chart
Since July 10, 2020, Cogent Biosciences's market cap has increased from $124.27M to $2.29B, an increase of 1,738.98%. That is a compound annual growth rate of 73.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 2.24B | 159.56% |
| Dec 31, 2024 | 861.60M | 70.14% |
| Dec 29, 2023 | 506.41M | -37.32% |
| Dec 30, 2022 | 807.97M | 136.30% |
| Dec 31, 2021 | 341.92M | -2.42% |
| Dec 31, 2020 | 350.40M | 181.97% |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |